Sentences with phrase «astellas pharma»

• BridgeBio Pharma, a Palo Alto, Calif. - based clinical - stage biopharmaceutical company, raised $ 135 million in funding.

Not only is the science around them advancing quickly, but the drugs are so complex that they are hard for generic producers to copy — an attractive prospect for big pharma.

In B.C. especially, companies such as QLT Inc., Angiotech Pharmaceuticals and Cardiome Pharma Corp. saw their valuations soar in the early 2000s, only to come crashing to earth by the end of the decade as a result of competitive pressures, regulatory snags, strategic blunders and deals gone awry.

«There are two ways to receive validation: from partnerships with big pharma and from smart investors,» Bloom says.

Japanese pharma giant Takeda will buy TiGenix, a Belgian biotech focused on stem cell therapies, for $ 630 million in cash.

The lines between Big Pharma and small biotech are eroding.

Here's how Martin Shkreli, a.k.a. the Pharma Bro and «the most hated CEO in America» spent yesterday afternoon — a day that turned out to be his last day of freedom for a while:

«The reason I'm here is that I was very excited about the problem that we weren't addressing in pharma — dealing with the 86 million people with pre-diabetes that can lead to a tsunami in health care costs,» he said, adding that «pharma is looking beyond the pill» and that «digital therapeutics will become therapeutics,» particularly when it comes to preventing disease.

The goal was to stop anti-competitive practices in legal settlements by established players in Big Pharma.

MS says longer term impact of $ AMZN entering pharmacy could be direct relationships w branded pharma = rebates passing back to consumers pic.twitter.com/QnO2dvFa 7s

These products — largely innovative and pricey specialty medications that include breakthrough Hepatitis C treatments and immuno - oncology drugs — reflect the increased productivity and improved pipelines of pharma's R&D departments in recent years.

Are you worried about the future of new drug creation, given the relative lack of early - stage pharma investing?

British pharma giant GlaxoSmithKline is seriously shaking up (among other things) its R&D operation as part of a bid to realize one billion pounds in annual savings.

The advantage of Zymeworks» strategy is that licensing platforms to big pharma entitles it to a combination of cash up front, milestone payments as the clients» research proceeds and potential royalties once one of the drugs developed on the platform reaches the market.

Should Big Pharma be nervous?

Danish pharma company Novo Nordisk (nvo), best known for its insulin - based treatments for diabetes, said Tuesday it's going to shift its focus slightly to fighting obesity, one of the primary causes of that disease.

Fidelity Investments - backed Innovent Biologics and Ascentage Pharma both plan to float in the second half of this year and are working with several advisers, they added.

Biotech and pharma companies will get a smaller tax credit for developing drugs for rare diseases.

While the early - stage company still mounted losses for the quarter, it received more revenue than expected as a result of its collaboration with pharma giant Pfizer.

Pharma continues to be the most research - intense branch, though, with Merck, Roche, Eli Lilly, and AstraZeneca all spending between 21 % and 25 % of revenue on R&D.

IDEA Pharma, a leading drug industry consultancy, has released its 2018 «Freshness Index» — one of my favorite parts of the firm's much - awaited annual Pharmaceutical Innovation Index (which is slated to arrive at the end of this month).

Here are a few things I learned at the J.P. Morgan Health Conference this week: (1) Vice-presidential motorcades tie up as much traffic as presidential ones; (2) San Francisco hotels have no compunction about charging pharma - sphere prices, especially when the city is overrun by pharma executives; (3) no one will ever know if you brought more than one blue blazer to a four - day meeting; and (4) in my next life I want to come back as Bryan Roberts.

PHARMA DEAL: Pharma giant GlaxoSmithKline just struck a $ 13 billion deal to buy Novartis out of their consumer healthcare joint venture for $ 13 billion, taking full control of its product line.

Pharma's favorite merger type may be coming back.

The pharmaceutical giant just signed an exclusive license to investigate whether Teijin Pharma's anti-tau antibody can be used to treat the disease.

The Amazon - Whole Foods deal hit pharma stocks, too.

You can't just go to your buddies in pharma.

Wu - Tang Clan is known globally for their lyrical kung fu references, heavy rhythms and songs like, «C.R.E.A.M.» Recently they've been in the news because «pharma bro» Martin Shkreli bought what is purported to be one - of - a-kind Wu - Tang Album for a reported $ 2 million.

Neil Woodford, the major U.K. fund manager who has waged a multi-year effort to convince pharma giant GlaxoSmithKline to split up its business units, has had enough.

On average, the 30 large and small pharmaceutical and biotech companies IDEA Pharma examined got just 11 % of their 2017 revenue from drugs developed within the past five years, says Mike Rea, the firm's CEO and one of the most insightful people I've met — no exaggeration — when it comes to pinpointing innovation choke points in the drug industry.

Tony Wood, the senior vice president of medicinal sciences at Pfizer, is taking up a new gig at British pharma giant GlaxoSmithKline, FiercePharma reports.

Jiangsu Hengrui is the largest listed pharma in China.

Victoria Noble, a marketer with the pharma giant Shire (shpg) spoke about her efforts to get consumers to «love their medicines.»

IDEA Pharma has released its 2018 Freshness Index for drug development.

Leslie Dan's latest company, Viventia Bio, looked all set for a robust 2015 and 2016 before a series of scandals at Valeant Pharmaceuticals brought Canada's whole biotech and pharma sector crashing down.

Big pharma's return on investment vis - a-vis R&D plummeted to a dismal 3.2 % in 2017 compared with 10.1 % in 2010.

-- Ahmed Albaiti, founder and CEO of Medullan, a digital health innovation company that works with payers, providers, and pharma on patient engagement.

In that regard, the picture above is worth a thousand words: Nearly all of Big Pharma is riding on fumes, it seems.

Big pharma is a popular target for righteous anger from many quarters, but Governor Brown's defense of the law rests on reducing income inequality rather than sticking it to the man for its own sake.

Carlo Russo, who used to run the rare disease R&D unit over at pharma giant GlaxoSmithKline, is heading over to Italian biotech Genenta Science.

Shkreli originally became infamous for his other former company Turing Pharma's 5,000 % price hike for a drug used by cancer and AIDS patients.

• Zealand Pharma, a Denmark - based biotech focused on peptide - based medicines for type 2 diabetes, has filed for an IPO of American Depository Shares.

The city is particularly rich in startups in the white hot smart cities sector, as well gaming, biotech, and pharma.

But the initiative comes with another huge financial prize for firms that successfully win FDA approval for these niche therapies: a priority review voucher that can be used to slash the regulatory period for a different experimental specialty treatment being developed by a drug maker or, more often, sold for potentially hundreds of millions of dollars to another pharma company.

For instance, legislators like Sens. Elizabeth Warren of Massachusetts, Bernie Sanders of Vermont, and Jeff Merkley of Oregon recently warned that Cures amounts to a big pharma giveaway which will weaken regulatory standards on drugs, provide a mere pittance to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA), and do nothing to confront the rising tide of high drug prices.

Kite Pharma, one of the companies chasing a new generation of cancer drugs called chimeric antigen receptor T - cell (CAR - T) therapies, announced a patient death in a clinical trial of its experimental KTE - C19.

Big biotech and pharma companies are absolutely dependent on being able to successfully innovate by partnering with and acquiring disruptive startups because of the nature of the patent cliff in pharmaceuticals.

But the tactics that made him a household name underscore some of pharma's most controversial pricing and business practices.

The company runs clinical studies on behalf of its multinational pharma clients in oncology, respiratory / infectious disease and central nervous system disorders.

• Circle Pharma, a Santa Cruz, Calif. - based biotech company, announced a $ 2 million expansion to its previously announced $ 4.5 million Series A funding round.